Compare Natera Inc. Common Stock (NTRA) vs Vishay Intertechnology Inc. Common Stock (VSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Vishay Intertechnology Inc. Common Stock — how do they compare? Natera Inc. Common Stock trades at $393.93 (market cap $57.03B), while Vishay Intertechnology Inc. Common Stock trades at $27.78 (market cap $4.43B). The key difference: Natera Inc. Common Stock is far larger — about 12.9× Vishay Intertechnology Inc. Common Stock's market cap, and Vishay Intertechnology Inc. Common Stock pays a 1.38% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Vishay Intertechnology Inc. Common Stock for 6 Days on average.
| NTRA | VSH | |
|---|---|---|
Market Cap | $57.03B | $4.43B |
Volume | 1,131,157 | 3,881,013 |
Sector | Health | Technology |
52-Week High | $425.64 | $64.90 |
52-Week Low | $179.42 | $11.82 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $56.18B | $4.23B |
Dividend Yield | — | 1.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Vishay Intertechnology (VSH) trades at $31.76, down 0.84% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with a high P/E ratio of 158.8 but improving profitability trends, with net income projected to turn positive in 2026. Recent news highlights the company's focus on EV and AI infrastructure solutions, positioning it for growth in key technology markets.
While analyst consensus remains positive with a $43 price target, investors face valuation concerns and execution risks. The technical outlook suggests near-term pressure, but long-term growth potential exists if the company can capitalize on automotive and AI semiconductor demand while improving profit margins from current low levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Vishay Intertechnology Inc. Common Stock
Vishay Intertechnology manufactures discrete semiconductors and passive electronic components. Its products include diodes, MOSFETs, resistors, capacitors, and sensors.
Read more on VSH →
